Document is current
Any future updates will be listed below
-
Authors
Cao, Xiaolong
Song, Zexuan
He, Ping
Li, Xinyue
Lei, Nan
Sun, Qian
Wang, Xue
Xing, Ruida
Zhao, Bing
Yang, Xinyu
Zhang, Zhiguo
Zhao, Yanlin
-
Funding
Funding for this research was provided by:
the capital health research and development of special (NO. 2022-1G-3012)
the National Key R&D Program of China (NO. 2022YFC2305200)
- License Information
-
More Information
Article History
Received: 15 April 2024
Accepted: 9 January 2025
First Online: 22 January 2025
Declarations
:
: In this study, all patients volunteered to participate with informed consent and the collected strains and patient information were kept strictly confidential, the research methods and protocols for the current study were carried out in accordance with relevant guidelines and regulations (declarations of Helsinki), which has been approved by The Ethics Committee of Beijing Changping Institute for Tuberculosis Prevention and Treatment (CJ-2023–001).
: Not applicable.
: The authors declare no competing interests.
